Glenmark Pharmaceuticals consolidated net profit declines 78.05% in the December 2017 quarter

Sales decline 11.83% to Rs 2171.51 crore

Net profit of Glenmark Pharmaceuticals declined 78.05% to Rs 104.74 crore in the quarter ended December 2017 as against Rs 477.10 crore during the previous quarter ended December 2016. Sales declined 11.83% to Rs 2171.51 crore in the quarter ended December 2017 as against Rs 2462.95 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales2171.512462.95 -12 OPM %14.8631.06 -PBDT229.06717.85 -68 PBT153.67655.33 -77 NP104.74477.10 -78

Powered by Capital Market - Live News